S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy in Chinese patients with nonsmall-cell lung cancer: A multicentre randomized controlled trial

BACKGROUND: The aim of this study was to investigate the efficacy and safety of S-1 plus cisplatin combined with concurrent radiotherapy (SCCCR) versus cisplatin alone combined with concurrent radiotherapy (CCCR) in Chinese patients with unresectable stage III nonsmall-cell lung cancer (NSCLC). METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Junfei, Xu, Jinquan, Wang, Xuehui, Zhao, Dejun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023868/
https://www.ncbi.nlm.nih.gov/pubmed/27603346
http://dx.doi.org/10.1097/MD.0000000000004557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023868/
https://www.ncbi.nlm.nih.gov/pubmed/27603346
http://dx.doi.org/10.1097/MD.0000000000004557

Ejemplares similares